No Data
Truist Financial Maintains Boston Scientific(BSX.US) With Buy Rating, Maintains Target Price $110
A Quick Look at Today's Ratings for Boston Scientific(BSX.US), With a Forecast Between $95 to $110
Bernstein Adjusts Price Target on Boston Scientific to $110 From $100, Keeps Outperform Rating
Are Boston Scientific Corporation (NYSE:BSX) Investors Paying Above The Intrinsic Value?
Boston Scientific to Acquire Remaining Ownership Stake in Bolt Medical for $664m
Analysts Offer Insights on Healthcare Companies: Boston Scientific (BSX), Biomea Fusion (BMEA) and Solid Biosciences (SLDB)
No Data
